NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-019-2010-2-US-03 Nitroxyl (HNO) Releasing Compounds And Uses Thereof In Treating Diseases US National Stage 13/582,487 8633177 Abandoned PDF
NIA E-275-2011-0-EP-06 Method for Diagnosing A Neurodegenerative Disease EP DIV 16204118.0 Abandoned
NIA E-275-2011-0-GB-20 Method for Diagnosing A Neurodegenerative Disease GB EP 16204118.0 Abandoned
NIA E-275-2011-0-CH-17 Method for Diagnosing A Neurodegenerative Disease CH EP 16204118.0 Abandoned
NIA E-275-2011-0-DE-18 Method for Diagnosing A Neurodegenerative Disease DE EP 16204118.0 Abandoned
NIA E-275-2011-0-FR-19 Method for Diagnosing A Neurodegenerative Disease FR EP 16204118.0 Abandoned
NIA E-275-2011-0-FI-09 Method for Diagnosing A Neurodegenerative Disease FI EP 12756550.5 Abandoned
NIA E-275-2011-0-FR-10 Method for Diagnosing A Neurodegenerative Disease FR EP 12756550.5 Abandoned
NIA E-275-2011-0-DE-07 Method for Diagnosing A Neurodegenerative Disease DE EP 12756550.5 Abandoned
NIA E-275-2011-0-DK-08 Method for Diagnosing A Neurodegenerative Disease DK EP 12756550.5 Abandoned
NIA E-275-2011-0-IS-12 Method for Diagnosing A Neurodegenerative Disease IS EP 12756550.5 Abandoned
NIA E-275-2011-0-NO-14 Method for Diagnosing A Neurodegenerative Disease NO EP 12756550.5 Abandoned
NIA E-275-2011-0-NL-13 Method for Diagnosing A Neurodegenerative Disease NL EP 12756550.5 Abandoned
NIA E-275-2011-0-GB-11 Method for Diagnosing A Neurodegenerative Disease GB EP 12756550.5 Abandoned
NIA E-275-2011-0-SE-15 Method for Diagnosing A Neurodegenerative Disease SE EP 12756550.5 Abandoned
NIA E-275-2011-0-EP-04 Method for Diagnosing A Neurodegenerative Disease EP National Stage 12756550.5 Abandoned
NIA E-275-2011-0-PCT-02 Method for Diagnosing A Neurodegenerative Disease PCT PCT PCT/GB2012/052140 Expired
NIDCR E-139-2011-1-US-01 AAV Mediated Aquarporin-1 Gene Transfer To Treat Sjogren's Syndrome US 61/695,753 Abandoned
NCI E-266-2009-0-US-03 Compositions And Methods For The Treatment Of Cancer US National Stage 13/581,999 8685416 Abandoned PDF
NHGRI E-094-2010-0-US-03 Adenosine Receptor Agonists For The Treatment And Prevention Of Vascular Or Joint Capsule Calcification Disorders US National Stage 13/582,035 Abandoned
NEI E-115-2010-0-JP-09 Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice JP National Stage 2012-555540 Abandoned
NCI E-262-2005-0-AU-15 Mutated Pseudomonas Exotoxins with Reduced Immunogenicity AU DIV 2012216642 Issued
NEI E-113-2010-0-SE-14 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation SE EP 11706137.4 Issued
NEI E-113-2010-0-CH-08 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation CH EP 11706137.4 Issued
NEI E-113-2010-0-GB-12 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation GB EP 11706137.4 Issued
NEI E-113-2010-0-ES-10 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation ES EP 11706137.4 Issued
NEI E-113-2010-0-DE-09 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation DE EP 11706137.4 Issued
NEI E-113-2010-0-FR-11 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation FR EP 11706137.4 Issued
NEI E-113-2010-0-IT-13 Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation IT EP 11706137.4 Issued
NCI E-050-2007-2-US-07 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma US DIV 13/595,192 Abandoned
NIAID E-131-2002-0-JP-27 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NKT CELLS JP DIV 2012-186893 Abandoned
NHLBI E-251-2009-0-US-04 Azicon Beam Polarization Devices US National Stage 13/581,107 9086509 Issued PDF
NIA E-049-2001-0-US-21 GLP-1, Exendin-4, Peptide Analogs And Uses Thereof US CON 13/594,313 8853160 Expired PDF
NIAID E-301-2009-0-US-03 RSV Immunogens, Antibodies and Compositions Thereof US National Stage 13/502,595 Abandoned
NCATS E-277-2012-0-US-01 Compositions And Methods For Treating Cancers US 61/692,843 Abandoned
NIDDK E-308-2006-3-US-02 Cross-Coupled Peptide Nucleic Acids For Detection Of Nucleic Acids Of Pathogens US CON 13/592,490 9156778 Issued PDF
NCI E-097-2010-0-US-06 Gene Sets For Detection Of Ultraviolet A Exposure And Methods Of Use Thereof US National Stage 13/580,832 8741561 Abandoned PDF
NCATS E-156-2012-0-US-01 Cancer Treatment by Combined Inhibition of Proteasome and Topoisomerase Activities US 61/692,560 Abandoned
NINR E-023-2010-0-US-03 Biomarkers For Acute Ischemic Stroke US National Stage 13/580,571 9200322 Issued PDF
NIDDK E-185-2012-0-US-01 IMAGING AND DIAGNOSTIC METHODS, SYSTEMS, AND COMPUTER-READABLE MEDIA US 61/692,191 Abandoned
NIAID E-246-2012-0-US-01 Engineered Anthrax Lethal Toxin For Targeted Delivery US 61/692,143 Abandoned
NCI E-198-2012-0-US-01 Mesothelin Domain-Specific Monoclonal Antibodies And Use Thereof US 61/691,719 Abandoned
NCI E-151-2011-0-US-02 Reduction Of TGFB Signaling In Myeloid Cells In The Treatment Of Cancer US ORD 13/589,769 9115371 Abandoned PDF
NCI E-048-2012-0-US-01 EXPRESSION OF PROTEIN-CODING AND NONCODING GENES AS PROGNOSTIC CLASSIFIER IN EARLY STAGE LUNG CANCER US 61/691,118 Expired
NIDDK E-231-2012-0-US-01 Capillary Viscometer And Multiscale Pressure Differential Measuring Device US 61/691,209 Abandoned
NCI E-289-2011-0-IN-10 YEAST-MUC1 IMMUNOTHERAPEUTIC COMPOSITIONS AND USES THEREOF IN National Stage 1981/DELNP/2014 Issued
NCI E-289-2011-0-CN-06 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF CN National Stage 201280051154.2 Issued
NCI E-289-2011-0-MX-08 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF MX National Stage MX/a/2014/001717 Issued
NCI E-289-2011-0-AU-12 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF AU National Stage 2012296425 Issued
NCI E-289-2011-0-SG-09 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF SG National Stage 2014009757 Issued